Skip to content

A clinical trial comparing casting and skin traction versus frame fixation to repair shin bone fractures

Feasibility of Ilizarov frame fiXation for closed Tibial fractures in Sierra Leone

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN51545197
Enrollment
40
Registered
2018-09-03
Start date
2018-11-01
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Closed tibial fractures Infections and Infestations Closed tibial fracture

Interventions

The trial is a before and after study design with 40 patients in total (20 in each arm). The first 20 receive treatment as usual, which consists of plaster of Paris with or without traction and a tota

Sponsors

The College of Medicine and Allied Health Sciences (COMAHS)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or older 2. Able to provide written informed consent 3. Diagnosis of a closed diaphyseal tibial fracture with no intraarticular extension, and amenable to limb-sparing surgery following radiographic investigation 4. Fractures must have an angular deformity of 10 degrees or greater, or a displacement of greater than 50% in any plane at entry into the trial 5. Fracture sustained within 3 weeks of eligibility assessment 6. American Society of Anaesthesiologists (ASA) physical status =3 7. Capable of completing required questionnaires at time of consent

Exclusion criteria

Exclusion criteria: 1. Open fractures 2. Undisplaced fractures 3. Concurrent fractures of any bone requiring operative or traction management (concurrent fracture of the ipsilateral fibular is permitted) 4. Pre-existing diabetes via finger prick capillary blood glucose check 5. Pre-existing neuropathy via clinical examination of a doctor 6. Pre-operative compartment syndrome via clinical examination of a doctor 7. Sickle cell disease by past medical history 8. Immunosuppression by past medical history 9. Pathological fractures by radiographic and clinical examination 10. Lower limb lymphatic filariasis by clinical examination 11. Any previous involvement in the before or after arm of the trial 12. Patients who reside outside of the Western region catchment area

Design outcomes

Primary

MeasureTime frame
The fracture angular deformity at 3 months post-management, as defined by overall angular deformity on long leg alignment views via anteroposterior and lateral plain radiographs

Secondary

MeasureTime frame
The following will be assessed after 30 and at 3 months post-management: 1. Length of hospital stay, defined as the time between registration into trial and actual discharge date or censored at end of trial follow-up 2. Date of being medically fit for discharge, defined as the time between entry into the trial and clinical assessment concluding the patient is medically fit for discharge or censored at end of trial follow-up 3. Time to fully weight bear, defined as the ability to mobilise unaided based on clinical evaluation by a member of the caring team 4. Time to patient rerun to work or pre-morbid responsibilities (e.g. caregiving) if not employed and is self-defined by patient 5. Patient self-reported functional status, assessed using the Lower Limb Functional Index (LLFI) 6. Quality of life, assessed using the EuroQol-5D (EQ5D)

Countries

Sierra Leone

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026